AktiVax
Aktiv Pharma Group is a Specialty Pharmaceutical company with CDMO capabilities developing drug products in proprietary and configurable prefilled delivery systems, emphasizing reliability, safety, usability, and drug stability. The company supports its mission of delivering peace of mind through innovative drug delivery platforms such as ARAI Autoinjector, PenPal self-injection platform, ARCH-Vial, and a contract development and manufacturing organization. With a strong IP portfolio and a focus on autoinjector technology, Aktiv has pivoted from supporting U.S. government needs to serving the commercial biopharma market, offering end-to-end development support for combination products.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Modular high-reliability autoinjector platform (field-grade)
A modular autoinjector platform engineered for high reliability and rugged environmental performance; supports single-step activation, multisensory feedback, configurable injection pressure/time, and multi-constituent or reconstitution configurations.
Pressurized-gas consumer autoinjector platform
A pressurized-gas-powered autoinjector platform intended for routine at-home self-injection; designed for versatility across drug types including biologics and high-viscosity formulations and engineered to be cost-competitive at scale.
Film-based prefilled container with valved port and protective shell
A flexible, high-barrier polymer film primary container enclosed in a rigid protective shell and incorporating a valved Luer-style port; intended as a glass-free substitute for single-dose presentations and reconstitution workflows.
Modular high-reliability autoinjector platform (field-grade)
A modular autoinjector platform engineered for high reliability and rugged environmental performance; supports single-step activation, multisensory feedback, configurable injection pressure/time, and multi-constituent or reconstitution configurations.
Pressurized-gas consumer autoinjector platform
A pressurized-gas-powered autoinjector platform intended for routine at-home self-injection; designed for versatility across drug types including biologics and high-viscosity formulations and engineered to be cost-competitive at scale.
Film-based prefilled container with valved port and protective shell
A flexible, high-barrier polymer film primary container enclosed in a rigid protective shell and incorporating a valved Luer-style port; intended as a glass-free substitute for single-dose presentations and reconstitution workflows.
Services
Integrated service offering covering device innovation, design customization, prototyping, equipment development, GMP assembly, and sterile fill-finish to support projects from concept through clinical lot production.
Integrated service offering covering device innovation, design customization, prototyping, equipment development, GMP assembly, and sterile fill-finish to support projects from concept through clinical lot production.
Expertise Areas
- Drug‑device combination product development
- Autoinjector and delivery system engineering
- Film-based primary container design
- GMP sterile fill‑finish and pilot manufacturing
Key Technologies
- High-barrier polymer film primary containers
- Pressurized-gas-powered injection mechanism
- Dual-chamber and multi-constituent reconstitution systems
- GMP sterile fill-finish processes
News & Updates
Company culture supporting a balanced lifestyle for employees and opportunities to work for a thriving company in the drug delivery technology marketplace.
Development of a robust, reliable autoinjector for the broader consumer market, leveraging military-grade autoinjector knowledge.
A vertically integrated organization providing end-to-end development and manufacturing services for drug-device combination products.
Over 43 issued patents and 57 pending applications supporting innovative drug delivery solutions.
Company culture supporting a balanced lifestyle for employees and opportunities to work for a thriving company in the drug delivery technology marketplace.
Development of a robust, reliable autoinjector for the broader consumer market, leveraging military-grade autoinjector knowledge.
A vertically integrated organization providing end-to-end development and manufacturing services for drug-device combination products.
Over 43 issued patents and 57 pending applications supporting innovative drug delivery solutions.